VirtualScopics Inc. a developer of image-related biomarkers, yesterday announced sales for Q2 2006 that were up close to $1.3 million, a 27 percent increase over the prior year and a 23 percent rise over Q1 2006. The company also reported revenues for the first half of 2006 that increased 35 percent over the first half of 2005.
   
The company also saw a Q2 net loss of $1,238,608, which included $564,733 of non-cash compensation expense related to the adoption of a new accounting rule.  Excluding non-cash items, the net loss for Q2 was $555,172, VirtualScopics said.